Effects of intravenous recombinant tissue-type plasminogen activator therapy on the incidence and associations of left ventricular thrombus in patients with a first acute Q wave anterior myocardial infarction
Authors:
- Abdul Razzak Al-YusufAAAbdul Razzak Al-Yusuf
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 122 (5) , 1251-1256
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The natural history of left ventricular thrombus in myocardial infarction: A rationale in support of masterly inactivityJACC, 1989
- Influence of thrombolytic treatment followed by full dose anticoagulation on the frequency of left ventricular thrombi in acute myocardial infarctionThe American Journal of Cardiology, 1989
- Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarctionThe American Journal of Cardiology, 1988
- A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionJACC, 1987
- Left ventricular thrombi diagnosed by echocardiography in patients with acute myocardial infarction treated with intracoronary streptokinase followed by intravenous heparinThe American Journal of Cardiology, 1985
- Left Ventricular Thrombosis, Wall Motion Abnormalities, and Blood Viscosity Changes after First Transmural Anterior Myocardial InfarctionChest, 1985
- Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarctionThe American Journal of Cardiology, 1984
- Left ventricular thrombi after acute myocardial infarctionPostgraduate Medical Journal, 1983
- Value of early two dimensional echocardiography in patients with acute myocardial infarctionThe American Journal of Cardiology, 1982
- Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial InfarctionNew England Journal of Medicine, 1981